Vanguard Group Inc. Purchases 172,271 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Vanguard Group Inc. lifted its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 2.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,618,404 shares of the company's stock after purchasing an additional 172,271 shares during the period. Vanguard Group Inc. owned 5.99% of Surgery Partners worth $161,282,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in SGRY. KBC Group NV increased its holdings in Surgery Partners by 66.1% during the fourth quarter. KBC Group NV now owns 3,962 shares of the company's stock worth $84,000 after buying an additional 1,577 shares during the last quarter. MeadowBrook Investment Advisors LLC grew its position in shares of Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock valued at $218,000 after acquiring an additional 1,460 shares during the period. Empowered Funds LLC bought a new position in shares of Surgery Partners in the 4th quarter valued at about $245,000. KLP Kapitalforvaltning AS acquired a new position in shares of Surgery Partners during the 4th quarter worth about $273,000. Finally, LPL Financial LLC raised its holdings in shares of Surgery Partners by 22.4% in the 4th quarter. LPL Financial LLC now owns 16,749 shares of the company's stock valued at $355,000 after purchasing an additional 3,062 shares during the period.

Analyst Ratings Changes

SGRY has been the subject of a number of research analyst reports. Bank of America began coverage on Surgery Partners in a report on Monday, December 16th. They set a "buy" rating and a $30.00 price target for the company. Royal Bank of Canada reiterated an "outperform" rating and set a $35.00 target price on shares of Surgery Partners in a research note on Tuesday, March 25th. Finally, Macquarie dropped their price target on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research note on Tuesday, March 11th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $36.63.

Remove Ads

Surgery Partners Stock Performance

SGRY traded up $0.12 during trading on Friday, hitting $20.99. The stock had a trading volume of 815,510 shares, compared to its average volume of 1,099,434. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The firm has a market cap of $2.68 billion, a price-to-earnings ratio of -43.73, a P/E/G ratio of 19.21 and a beta of 2.40. The company has a 50 day moving average price of $23.99 and a 200-day moving average price of $24.76. Surgery Partners, Inc. has a one year low of $19.50 and a one year high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings results on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating the consensus estimate of $0.38 by $0.01. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business had revenue of $864.40 million for the quarter, compared to the consensus estimate of $828.09 million. As a group, research analysts predict that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Insiders Place Their Bets

In other Surgery Partners news, insider Marissa Brittenham sold 3,156 shares of Surgery Partners stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the completion of the transaction, the insider now directly owns 63,408 shares of the company's stock, valued at $1,527,498.72. The trade was a 4.74 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO David T. Doherty sold 6,733 shares of the stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.02, for a total value of $161,726.66. Following the sale, the chief financial officer now directly owns 150,868 shares in the company, valued at approximately $3,623,849.36. This trade represents a 4.27 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 106,622 shares of company stock worth $2,717,860 in the last quarter. Corporate insiders own 2.30% of the company's stock.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.